GeneDx Appoints Everett Cunningham as New CEO

GeneDx (WGS) has announced the appointment of Everett Cunningham as its new Chief Executive Officer and a member of its board of directors. The transition is scheduled to take effect on or before December 15, 2026. Cunningham will succeed Katherine Stueland, who is stepping down from her role at the company. This leadership change marks a planned succession for the genomic testing provider.

5 articles from 3 sources · updated

Coverage